June 5, 2019

Pillet S et al. PLoS One 2019;14(6):e0216533.

Immunogenicity and Safety of a Quadrivalent Plant-derived Virus Like Particle Influenza Vaccine Candidate – Two Randomized Phase II Clinical Trials in 18 to 49 and ≥50 Years Old Adults

Download publication

You might also be interested by

Brochures

High Performance Technologies for Cytokine Measurement

November 8, 2021

Immune Monitoring

More info

Brochures

Cell Therapy

November 5, 2021

Histopathology

More info

Brochures

Oncology & Immuno-Oncology Expertise

November 5, 2021

Histopathology

More info

Infographics

Advance Your Cell Therapy with Cross-Platform Capabilities

November 5, 2021

Histopathology

More info